The Key For S6 Kinase

Матеріал з HistoryPedia
Версія від 13:07, 19 травня 2017, створена Salebabies1 (обговореннявнесок) (Створена сторінка: We determined urban, large rural, small rural, and isolated status by linking the ZIP code to the Rural-Urban [http://en.wikipedia.org/wiki/Ribosomal_s6_kinase...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

We determined urban, large rural, small rural, and isolated status by linking the ZIP code to the Rural-Urban S6 Kinase Commuting Area Codes (RUCA) Version 2.0.[14] We analyzed data from all Diabetes PPM's completed from 2005 to 2012. We used the PPM as the unit of analysis, as physicians may repeat the PPM multiple times, and we were unable to control for this, given the inability to link each physician with their PPM. We excluded PPMs done by physicians in residency, those with incomplete quality data, and those residing outside the 50 states of the United States or Washington, DC. We used descriptive statistics to characterize available physician demographics and to calculate the mean or proportion of quality measures, counts of quality measures, Chronic Care Model domain, and intervention chosen. Statistical tests for differences between pre- and postinterventions were done using either t-tests or chi-square tests. We performed a separate multiple regression analysis for each of the 7 chart-abstracted indicators and 8 patient survey quality indicators. For the chart-abstracted measures, these were operationalized as (1) hemoglobin A1c value www.selleckchem.com/products/LY294002.html blood pressure; (2) having your urine checked for signs of diabetic kidney disease this year; (3) if you smoke, being counseled on smoking cessation; (4) A1c checked in the past 6 months; (5) blood pressure measurement during today's visit; (6) having an eye exam in the past 12 months; (7) having cholesterol checked in the past year; and (8) having your feet examined in the past 6 months. For each of these measures, an aggregate percentage was calculated for both pre- and postintervention measures and the change in percentage (between �C1 and 1) was Lapatinib ic50 used as the outcome in linear regression models. The interpretation of the ��-coefficient in these models is the percent change in the outcome associated with a unit increase, or having a characteristic as opposed to not, in an independent variable. For example, a �� of 0.02 for ��standing order�� in the regression for A1c would mean that using a standing order as an intervention was associated with a 2% increase in the proportion of patients with an A1c